Moderna (MRNA) Tops Q1 EPS by 194c

Moderna (NASDAQ: MRNA) reported Q1 EPS of $0.19, $1.94 better than the analyst estimate of ($1.75). Revenue for the quarter came in at $1.9 billion versus the consensus estimate of $1.18 billion.

For earnings history and earnings-related data on Moderna (MRNA) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Lennar Corp. (LEN) Misses Q2 EPS by 1c
• Carvana (CVNA) PT Lowered to $85 at RBC Capital